Indications -- Sepsis/Acute Inflammation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Indications -- Sepsis/Acute Inflammation

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (25)	10/21/2003 10:22:49 AM
From: nigel bates	Read Replies (1) of 89

Dunno. I can't see what they have to gain by hyping it now. They've done their fundraising (albeit small) and they'd need something better than this announcement to do another. Genentech licensed the rights for this indication, and the news isn't going to be of much use in attracting a partner for oncology - so what do they have to gain ? Genentech have had the license for about 18 months now. If they were going to do anything with it, how soon would you expect to hear something ?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next